The Orlando Health Heart Institute’s Pulmonary Hypertension Program was recently recognized as an accredited comprehensive care center through the Pulmonary Hypertension…
Articles by Patrícia Silva, PhD
Don Stevenson, also known as the Pacing Parson, is marking his 80th birthday with a 1,000-mile benefit and awareness walk for the…
The Pulmonary Hypertension Association (PHA) recently announced the three pulmonary hypertension (PH) researchers chosen to receive its 2015 Robyn…
The Pulmonary Hypertension Association (PHA) announced that three more centers recently received Pulmonary Hypertension Care Center (PHCC) accreditation, raising the total…
Actelion Pharmaceuticals, Ltd., recently announced that the selective IP receptor agonist Uptravi (selexipag) has been granted Notice of Compliance (NOC)…
The phaware global association knows the soon-to-be-played Super Bowl 50 will attract plenty of fans and attention — and it’s teaming with the…
Work on a doctoral dissertation at Umeå University in Sweden led to the discovery of new blood biomarkers reflecting vasoreactivity in…
Morphogen-IX, a new biotechnology company based in Cambridge, United Kingdom, has received financial support to potentially advance a new treatment for pulmonary…
The Pulmonary Hypertension Association (PHA) is celebrating its 25th birthday in 2016 by highlighting major Pulmonary Hypertension treatment advances made over the past…
A new study is investigating whether tocilizumab, an immunosuppressive drug mainly used as a therapy for rheumatoid arthritis and systemic juvenile…
The legendary singer Natalie Cole, the daughter of Nat King Cole, died on New Year’s Eve at the Cedars-Sinai Hospital in…
Data from a Phase 3 clinical trial showed that patients with pulmonary arterial hypertension (PAH) might benefit from selexipag treatment, as the…